News ObsEva SA

Equities

OBSN

CH1260041939

End-of-day quote Swiss Exchange Other stock markets 03:30:00 03/05/2024 am IST			5-day change	1st Jan Change
0.0012 ^CHF	-76.92%		-81.25%	-96.63%

03/04	ObsEva to Delist from the SIX Swiss Exchange	MT
20/03	ObsEva SA Announces to Wind-Down the Operations	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ObsEva to Delist from the SIX Swiss Exchange	03/04	MT
ObsEva SA Announces to Wind-Down the Operations	20/03	CI
ObsEva SA Announces Catarina Edfjäll to Step Down from the Board	20/03	CI
ObsEva to Wind Down, Flags SIX Swiss Delisting	28/02	MT
ObsEva Secures Temporary Moratorium Against Creditors	31/01	MT
ObsEva to File for Moratorium in Geneva, Switzerland	30/11	MT
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals	30/11	AQ
ObsEva to Return Global Rights on Ebopiprant to Xoma	30/23/30	MT
Organon Returns Ebopiprant to XOMA	28/23/28	AQ
ObsEva Net Loss Narrows in H1	27/23/27	MT
ObsEva SA Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27	CI
ObsEva Terminates Licensing Deal with Yuyuan BioScience for Oral Oxytocin Receptor	13/23/13	MT
ObsEva Recovers Full Worldwide Rights on Nolasiban	13/23/13	AQ
ObsEva SA Announces Termination of Its Sub-Licensing Agreement with Yuyuan Bioscience	13/23/13	CI
SIX Group Makes Index Adjustments Following Review	12/23/12	MT
Switzerland's ObsEva Appoints Permanent CEO	02/23/02	MT
ObsEva SA announced that it expects to receive CHF 1.54 million in funding from ObsEva USA Inc.	08/22/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW